HK1149937A1 - An anti-carcinoembryonic antigen antibody and its application - Google Patents

An anti-carcinoembryonic antigen antibody and its application

Info

Publication number
HK1149937A1
HK1149937A1 HK11104115.9A HK11104115A HK1149937A1 HK 1149937 A1 HK1149937 A1 HK 1149937A1 HK 11104115 A HK11104115 A HK 11104115A HK 1149937 A1 HK1149937 A1 HK 1149937A1
Authority
HK
Hong Kong
Prior art keywords
application
carcinoembryonic antigen
antigen antibody
antibody
carcinoembryonic
Prior art date
Application number
HK11104115.9A
Other languages
English (en)
Original Assignee
Shanghai Haikang Pharmaceutical Tech & Deve Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Haikang Pharmaceutical Tech & Deve Co filed Critical Shanghai Haikang Pharmaceutical Tech & Deve Co
Publication of HK1149937A1 publication Critical patent/HK1149937A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3007—Carcino-embryonic Antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK11104115.9A 2010-05-05 2011-04-26 An anti-carcinoembryonic antigen antibody and its application HK1149937A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010101630522A CN101928347B (zh) 2010-05-05 2010-05-05 抗癌胚抗原抗体及其应用

Publications (1)

Publication Number Publication Date
HK1149937A1 true HK1149937A1 (en) 2011-10-21

Family

ID=43367813

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11104115.9A HK1149937A1 (en) 2010-05-05 2011-04-26 An anti-carcinoembryonic antigen antibody and its application

Country Status (9)

Country Link
US (1) US9056911B2 (pl)
EP (1) EP2567982B1 (pl)
JP (2) JP5987822B2 (pl)
CN (1) CN101928347B (pl)
CA (1) CA2798285C (pl)
ES (1) ES2655998T3 (pl)
HK (1) HK1149937A1 (pl)
PL (1) PL2567982T3 (pl)
WO (1) WO2011137687A1 (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101928347B (zh) * 2010-05-05 2013-03-27 上海海抗中医药科技发展有限公司 抗癌胚抗原抗体及其应用
EP3252076B1 (en) 2011-01-14 2019-09-04 The Regents Of The University Of California Diagnostic use of antibodies against ror-1 protein
RU2493166C1 (ru) * 2012-04-09 2013-09-20 Общество с ограниченной ответственностью "Технофарма" Наноантитело, специфически связывающее белок сеа, способ его использования для детекции этого белка
US10656156B2 (en) * 2012-07-05 2020-05-19 Mepur Ravindranath Diagnostic and therapeutic potential of HLA-E monospecific monoclonal IgG antibodies directed against tumor cell surface and soluble HLA-E
CN104628859A (zh) * 2015-01-26 2015-05-20 佳德资本投资管理（Bvi）有限公司 抗人癌胚抗原抗体及其编码基因和应用
HUE058689T2 (hu) 2016-11-18 2022-09-28 Astellas Pharma Inc Új humán MUC1 elleni antitest FAB fragmense
CN106749667B (zh) * 2016-12-04 2020-07-14 深圳市国创纳米抗体技术有限公司 一种抗癌胚抗原的纳米抗体及其应用
CA3054738A1 (en) * 2017-02-27 2018-08-30 Dragonfly Therapeutics, Inc. Multispecific binding proteins targeting cea
TWI795415B (zh) 2017-07-07 2023-03-11 日商安斯泰來製藥股份有限公司 新穎的抗人類ＣＥＡＣＡＭ５抗體Ｆａｂ片段
TW201922796A (zh) * 2017-10-30 2019-06-16 國立研究開發法人國立癌症研究中心 可用於實體腫瘤治療之抗體及其抗體－藥物共軛物以及含其之抗癌劑
CN110297093B (zh) * 2019-03-18 2022-04-22 山西瑞豪生物科技有限公司 一种检测人免疫球蛋白g4的方法和试剂盒
CN114409789B (zh) * 2022-03-30 2022-06-07 北京科跃中楷生物技术有限公司 一种胶体金颗粒标记方法及检测试剂盒
CN114560944B (zh) * 2022-03-30 2022-08-09 北京科跃中楷生物技术有限公司 胶体金颗粒标记的抗体及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874540A (en) * 1994-10-05 1999-02-23 Immunomedics, Inc. CDR-grafted type III anti-CEA humanized mouse monoclonal antibodies
CN1216321A (zh) * 1997-10-31 1999-05-12 广州军区广州总医院医务部科训科 癌胚抗原基因启动子dna的克隆方法、序列及其用途
CN1077801C (zh) * 1997-11-19 2002-01-16 中国科学院微生物研究所 癌胚抗原基因工程抗体CL-3-scFv
US20040096826A1 (en) 2002-01-30 2004-05-20 Evans Glen A. Methods for creating recombination products between nucleotide sequences
US7232888B2 (en) * 2002-07-01 2007-06-19 Massachusetts Institute Of Technology Antibodies against tumor surface antigens
CN1532281A (zh) * 2003-03-21 2004-09-29 吉林大学第一医院 癌胚抗原基因片段的重组及基因疫苗
JP4908440B2 (ja) * 2008-03-06 2012-04-04 株式会社東芝 画像処理装置及び方法
CN101928347B (zh) * 2010-05-05 2013-03-27 上海海抗中医药科技发展有限公司 抗癌胚抗原抗体及其应用

Also Published As

Publication number Publication date
JP2013534406A (ja) 2013-09-05
US20130123471A1 (en) 2013-05-16
JP2016028577A (ja) 2016-03-03
CN101928347A (zh) 2010-12-29
JP5987822B2 (ja) 2016-09-07
CA2798285A1 (en) 2011-11-10
US9056911B2 (en) 2015-06-16
EP2567982A4 (en) 2013-09-18
EP2567982B1 (en) 2017-11-01
WO2011137687A1 (zh) 2011-11-10
EP2567982A1 (en) 2013-03-13
PL2567982T3 (pl) 2018-04-30
ES2655998T3 (es) 2018-02-22
CA2798285C (en) 2017-06-06
CN101928347B (zh) 2013-03-27

Similar Documents

Publication Publication Date Title
HUS2000056I1 (hu) ANTI-PD-L1 ellenanyagok és alkalmazásaik
HRP20182098T1 (hr) Anti-angptl3 antitijela i njihove primjene
HK1216540A1 (zh) 抗體及其用途
HK1149937A1 (en) An anti-carcinoembryonic antigen antibody and its application
EP2525813A4 (en) ANTIBODIES TO ILT5 AND ILT5 BINDING ANTIBODY FRAGMENTS
HK1200853A1 (en) Meditopes and meditope-binding antibodies and uses thereof
IL225484A0 (en) Anti-48cd antibodies and their uses
EP2585476A4 (en) ANTIGENS AND ANTIBODIES SPECIFIC TO COLON AND PANCREATIC CANCER
PL2946791T3 (pl) Przeciwciała anty-CD277 i ich zastosowania
PL2510011T3 (pl) Przeciwciała monoklonalne, które wiążą B7H6 i ich zastosowania
EP2593475A4 (en) ANTI-ADDL MONOCLONAL ANTIBODY AND USES THEREOF
HK1180601A1 (zh) 抗體製劑
HK1179981A1 (zh) 的抗體及其用途
EP2525822A4 (en) IMMUNOREGULATION WITH ANTI-ILT5 ANTIBODIES AND ILT5-BINDING ANTIBODY FRAGMENTS
EP2632949A4 (en) SPECIFIC ANTIBODIES OF DIFFICULT CLOSTRIDIUM AND THEIR APPLICATIONS
EP2632952A4 (en) ANTI-SOD1 ANTIBODIES AND USES THEREOF
PL2621955T3 (pl) Przeciwciała anty-CEACAM6 i ich zastosowania
EP2650367A4 (en) HUMAN MONOCLONAL ANTIBODY
EP2554552A4 (en) NOVEL ANTI-CD98 ANTIBODIES AND USE THEREOF
EP2620449A4 (en) EPIDINATED ANTIBODIES AGAINST B2 AND THE USE THEREOF
EP2659273A4 (en) MONOCLONAL ANTIBODIES TO ALPHA-ACTININ-4-ANTIGENS AND THEIR USE
EP2771689A4 (en) PEPTIDES USP2A AND ANTIBODIES
EP2578682A4 (en) ANTIBODIES AND ITS USE
EP2545378A4 (en) ANTI-LG3 ANTIBODIES AND USES THEREOF